Supplementary Table 5 from CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial

MLA

Olivier Colomban, et al. Supplementary Table 5 from CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22477413.v1.

APA

Olivier Colomban, Gilles Freyer, Eric Pujade-Lauraine, Alexandra Leary, Florence Joly, Annick Chevalier-Place, Pierre Combe, Isabelle Ray-Coquard, Gaëtan De Rauglaudre, Gwénael Ferron, Francesco Del Piano, Marianne Leheurteur, Philippe Follana, Jean-Emmanuel Kurtz, Nathalie Bonichon-Lamichhane, Christophe Desauw, Michel Fabbro, Sophie Abadie-Lacourtoisie, Jean-Pierre Lotz, … Benoit You. (2023). Supplementary Table 5 from CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial. https://doi.org/10.1158/1078-0432.22477413.v1

Chicago

Olivier Colomban, Gilles Freyer, Eric Pujade-Lauraine, Alexandra Leary, Florence Joly, Annick Chevalier-Place, Pierre Combe, et al. 2023. “Supplementary Table 5 from CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial,” March. doi:10.1158/1078-0432.22477413.v1.